China (People’s Republic of) vs Rwanda: Dealing with construction permits: Building quality control index
China (People’s Republic of)
100
in 2019
Rwanda
100
in 2019
China (People’s Republic of) rank
1st
Rwanda rank
1st
Dealing with construction permits: Building quality control index over time
- China (People’s Republic of)
- Rwanda
How they compare
China (People’s Republic of) currently reports 100 against 100 in Rwanda, a difference of 0.
Across all 6 years both countries report, Rwanda has been ahead every year.
China (People’s Republic of) ranks 1st and Rwanda ranks 1st of 190 countries.
Rwanda has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher dealing with construction permits: building quality control index, China (People’s Republic of) or Rwanda?
- China (People’s Republic of), at 100 against 100 in Rwanda as of 2019.
- What is the difference in dealing with construction permits: building quality control index between China (People’s Republic of) and Rwanda?
- 0, with China (People’s Republic of) ahead.
- How many years of comparable data are there for China (People’s Republic of) and Rwanda?
- 6 years are reported by both, from 2014 to 2019.
- How do China (People’s Republic of) and Rwanda rank globally for dealing with construction permits: building quality control index?
- China (People’s Republic of) ranks 1st and Rwanda ranks 1st of 190 countries.
- Where does this data come from?
- The World Bank, published as Dealing with construction permits: Building quality control index (0-15) (DB16-20 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The score for the building quality control index benchmarks economies with respect to the regulatory best practice on the indicator. The score ranges from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB16-20 studies.